U.S. Stem Cell, Inc. (USRM) financial statements (2021 and earlier)

Company profile

Business Address 1560 SAWGRASS CORPORATE PKWY
SUNRISE, FL 33323
State of Incorp. FL
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0111122
Cash and cash equivalents0111122
Receivables0000000
Inventory, net of allowances, customer advances and progress billings0000000
Inventory0000000
Other undisclosed current assets0000000
Total current assets:0112222
Noncurrent Assets
Operating lease, right-of-use asset000
Property, plant and equipment0000000
Deposits noncurrent assets0000000
Other undisclosed noncurrent assets 000000
Total noncurrent assets:0000000
TOTAL ASSETS:1112222
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2222323
Accounts payable1111111
Accrued liabilities1111111
Settlement liabilities0000000
Deferred revenue000
Debt2101122
Due to related parties0000000
Other undisclosed current liabilities5423332
Total current liabilities:9866677
Noncurrent Liabilities
Long-term debt and lease obligation1111111
Long-term debt, excluding current maturities0111111
Capital lease obligations0000
Operating lease, liability0  
Liabilities, other than long-term debt0000000
Deferred revenue000
Deferred gain on sale of property  00000
Other undisclosed noncurrent liabilities  11101
Total noncurrent liabilities:1133322
Total liabilities:10989999
Stockholders' equity
Stockholders' equity attributable to parent(9)(8)(7)(7)(7)(7)(6)
Common stock0000000
Common stock, value, subscriptions      0
Additional paid in capital123123123123122122121
Accumulated deficit(133)(131)(130)(130)(129)(129)(128)
Total stockholders' equity:(9)(8)(7)(7)(7)(7)(6)
TOTAL LIABILITIES AND EQUITY:1112222

Income statement (P&L) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues0112222
Cost of revenue
(Cost of Goods and Services Sold)
(0)(1)(1)(0)(1)(1)(1)
Gross profit:0111111
Operating expenses(2)(1)(1)(1)(1)(2)(1)
Operating loss:(2)(1)(0)(0)(0)(1)(0)
Nonoperating expense(0)(0)(0)(0)(0)(0)(0)
Investment income, nonoperating   0000
Other nonoperating income0 0    
Interest and debt expense00(0)(0)0(0)(0)
Loss from continuing operations before equity method investments, income taxes:(2)(1)(1)(0)(0)(1)(0)
Other undisclosed income (loss) from continuing operations before income taxes(0)(0)00(0)00
Net loss:(2)(1)(1)(0)(0)(1)(0)
Other undisclosed net loss attributable to parent    (0)  
Net loss available to common stockholders, diluted:(2)(1)(1)(0)(0)(1)(0)

Comprehensive Income ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net loss:(2)(1)(1)(0)(0)(1)(0)
Comprehensive loss, net of tax, attributable to parent:(2)(1)(1)(0)(0)(1)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: